Biosecurity and Vaccine Development Improvement Act of 2010
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2010 · fourth_quarter · Homeland Security
Issues related to homeland security. S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines. S 3140, Biosecurity and Vaccine Development Improvement Act. Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis. HR 5498, WMD Prevention & Preparedness Act of 2010.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2010 · fourth_quarter · Homeland Security
No specific bill number: matters relating to the BioShield Project. S.3140: Biosecurity and Vaccine Development Improvement Act: entire bill.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Homeland Security
Issues related to homeland security. S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines. S 3140, Biosecurity and Vaccine Development Improvement Act. Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis. HR 5498, WMD Prevention & Preparedness Act of 2010.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2010 · third_quarter · Homeland Security
No specific bill number: matters relating to the BioShield Project. S.3140: Biosecurity and Vaccine Development Improvement Act: entire bill.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Homeland Security
No specific bill number: matters relating to the BioShield Project. S.3140: Biosecurity and Vaccine Development Improvement Act: entire bill.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Homeland Security
Issues related to homeland security. S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines. S 3140, Biosecurity and Vaccine Development Improvement Act. Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis. HR 5498, WMD Prevention & Preparedness Act of 2010.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2010 · first_quarter · Homeland Security
Issues related to homeland security. S 1649 WMD Prevention and Prepardeness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShied related to stockpiling of biodefense vaccines. S 3140, Biosecurity and Vaccine Development Improvement Act. Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2010 · first_quarter · Science/Technology
HR 2432 "American Clean Energy & Security Act" - sections pertaining to energy research & development no bill - Department of Defense support of social science research as it relates to military training, recruiting and family life issues S. 3140 "Biosecurity and Vaccine Development Improvement Act of 2010" no bill - Department of Commerce plans for new Office of Innovation & Entrepreneurship and Tech Transfer no bill - reauthorization of America COMPETES Act
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Natl Institute of Standards & Technology (NIST), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA)
2010 · first_quarter · Homeland Security
No specific bill number: matters relating to the BioShield Project. S.3140: Biosecurity and Vaccine Development Improvement Act: entire bill.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE